FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8,119,847 | -48.6% | 804,742 | +14.1% | 0.00% | -50.0% |
Q3 2022 | $15,799,364 | -9.6% | 705,014 | 0.0% | 0.00% | -20.0% |
Q2 2022 | $17,470,247 | -19.3% | 705,014 | +26.2% | 0.01% | 0.0% |
Q1 2022 | $21,658,008 | -53.1% | 558,628 | -29.2% | 0.01% | -44.4% |
Q4 2021 | $46,191,000 | +2.0% | 789,454 | +3.4% | 0.01% | -10.0% |
Q3 2021 | $45,272,000 | -28.3% | 763,829 | +5.0% | 0.01% | -28.6% |
Q2 2021 | $63,145,000 | -6.6% | 727,557 | -11.3% | 0.01% | -6.7% |
Q1 2021 | $67,642,000 | -11.5% | 820,405 | -2.4% | 0.02% | -16.7% |
Q4 2020 | $76,446,000 | +118.9% | 840,713 | -3.8% | 0.02% | +100.0% |
Q3 2020 | $34,930,000 | +1113.3% | 873,914 | +941.6% | 0.01% | +800.0% |
Q2 2020 | $2,879,000 | – | 83,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |